78 related articles for article (PubMed ID: 9191049)
1. Bcl-2 reduces lymphomagenesis in deltaV-TCRbeta transgenic mice.
Acton D; Jacobs H; Domen J; Berns A
Oncogene; 1997 May; 14(21):2497-501. PubMed ID: 9191049
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic potential of a pre-T cell receptor lacking the TCR beta variable domain.
Jacobs H; Ossendorp F; de Vries E; Ungewiss K; von Boehmer H; Borst J; Berns A
Oncogene; 1996 May; 12(10):2089-99. PubMed ID: 8668334
[TBL] [Abstract][Full Text] [Related]
3. Role of Bcl-2 in alpha beta T cell development in mice deficient in the common cytokine receptor gamma-chain: the requirement for Bcl-2 differs depending on the TCR/MHC affinity.
Nakajima H; Leonard WJ
J Immunol; 1999 Jan; 162(2):782-90. PubMed ID: 9916699
[TBL] [Abstract][Full Text] [Related]
4. Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells.
Cory S; Harris AW; Strasser A
Philos Trans R Soc Lond B Biol Sci; 1994 Aug; 345(1313):289-95. PubMed ID: 7846127
[TBL] [Abstract][Full Text] [Related]
5. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
6. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
[TBL] [Abstract][Full Text] [Related]
7. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.
Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD
Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
Vail ME; Pierce RH; Fausto N
Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
[TBL] [Abstract][Full Text] [Related]
9. E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells.
Strasser A; Harris AW; Cory S
Oncogene; 1993 Jan; 8(1):1-9. PubMed ID: 8423986
[TBL] [Abstract][Full Text] [Related]
10. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression.
Grossmann M; O'Reilly LA; Gugasyan R; Strasser A; Adams JM; Gerondakis S
EMBO J; 2000 Dec; 19(23):6351-60. PubMed ID: 11101508
[TBL] [Abstract][Full Text] [Related]
11. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF.
Tardivel A; Tinel A; Lens S; Steiner QG; Sauberli E; Wilson A; Mackay F; Rolink AG; Beermann F; Tschopp J; Schneider P
Eur J Immunol; 2004 Feb; 34(2):509-18. PubMed ID: 14768056
[TBL] [Abstract][Full Text] [Related]
12. Induction of tolerance to immunogenic tumor antigens associated with lymphomagenesis in HOX11 transgenic mice.
Rosic-Kablar S; Chan K; Reis MD; Dubé ID; Hough MR
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13300-5. PubMed ID: 11069299
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2.
Lu L; Chaudhury P; Osmond DG
J Immunol; 1999 Feb; 162(4):1931-40. PubMed ID: 9973461
[TBL] [Abstract][Full Text] [Related]
14. Participation of the Bcl-2 and Fas molecules in experimental apoptosis of spleen B lymphocytes.
Alvarado C; Alarcón-Riquelme ME; Alcocer-Varela J; Fernández C
Rev Invest Clin; 1997; 49(3):171-8. PubMed ID: 9294959
[TBL] [Abstract][Full Text] [Related]
15. Somatic hypermutation of Ig genes is affected differently by failures in apoptosis caused by disruption of Fas (lpr mutation) or by overexpression of Bcl-2.
Mastache EF; Lindroth K; Fernández C; González-Fernández A
Scand J Immunol; 2006 Jun; 63(6):420-9. PubMed ID: 16764695
[TBL] [Abstract][Full Text] [Related]
16. APRIL modulates B and T cell immunity.
Stein JV; López-Fraga M; Elustondo FA; Carvalho-Pinto CE; Rodríguez D; Gómez-Caro R; De Jong J; Martínez-A C; Medema JP; Hahne M
J Clin Invest; 2002 Jun; 109(12):1587-98. PubMed ID: 12070306
[TBL] [Abstract][Full Text] [Related]
17. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M
Oncogene; 1999 Nov; 18(50):7124-34. PubMed ID: 10597314
[TBL] [Abstract][Full Text] [Related]
18. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis.
Hotchkiss RS; Swanson PE; Knudson CM; Chang KC; Cobb JP; Osborne DF; Zollner KM; Buchman TG; Korsmeyer SJ; Karl IE
J Immunol; 1999 Apr; 162(7):4148-56. PubMed ID: 10201940
[TBL] [Abstract][Full Text] [Related]
20. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways.
Kim K; Lee CK; Sayers TJ; Muegge K; Durum SK
J Immunol; 1998 Jun; 160(12):5735-41. PubMed ID: 9637482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
